Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 10 for ENFORTUMAB VEDOTIN
  1. Enfortumab vedotin-ejfv Injection 
    Enfortumab vedotin-ejfv injection is used alone or in combination with pembrolizumab (Keytruda) to treat urothelial cancer (cancer ... these chemotherapy medications cannot be used for treatment. Enfortumab vedotin-ejfv injection is in a class of medications ...
    https://medlineplus.gov/druginfo/meds/a620005.html - Drugs and Supplements
  2. Treatment of Bladder Cancer by Stage From the National Institutes of Health (National Cancer Institute)  
    Bladder Cancer/Treatments and Therapies ... Bladder Cancer ... National Cancer Institute ... From the National Institutes of Health ... Learn how bladder cancer is treated, ...
    https://www.cancer.gov/types/bladder/treatment/by-stage - National Institutes of Health
  3. Advances in Bladder Cancer Research From the National Institutes of Health (National Cancer Institute)  
    Bladder Cancer/Statistics and Research ... Bladder Cancer ... National Cancer Institute ... From the National Institutes of Health ... An overview of what's new, recent research ...
    https://www.cancer.gov/types/bladder/research - National Institutes of Health
  4. List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016 (Centers for Disease Control and Prevention)  
    Occupational Health for Health Care Providers/Related Issues ... Occupational Health for Health Care Providers ... Centers for Disease Control and Prevention ... Preventing ...
    https://www.cdc.gov/niosh/docs/2016-161/default.html - External Health Links
  5. Drugs Approved for Kidney (Renal Cell) Cancer From the National Institutes of Health (National Cancer Institute)  
    Kidney Cancer/Treatments and Therapies ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved ...
    https://www.cancer.gov/about-cancer/treatment/drugs/kidney - National Institutes of Health
  6. Drugs Approved for Bladder Cancer From the National Institutes of Health (National Cancer Institute)  
    Bladder Cancer/Treatments and Therapies ... Bladder Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved ...
    https://www.cancer.gov/about-cancer/treatment/drugs/bladder - National Institutes of Health
  7. Bladder cancer 
    ... In these people, chemotherapy, the antibody-drug conjugate enfortumab vedotin (Padcev), targered therapy, and immunotherapy are often considered. ...
    https://medlineplus.gov/ency/article/000486.htm - Medical Encyclopedia
  8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury From the National Institutes of Health (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)  
    Medicines/Statistics and Research ... Medicines ... Liver Diseases/Statistics and Research ... Liver Diseases ... National Library of Medicine ... National Institute of Diabetes ...
    https://www.ncbi.nlm.nih.gov/books/NBK547852 - National Institutes of Health
  9. Bladder Cancer Treatment From the National Institutes of Health (National Cancer Institute)  
    Bladder Cancer/Treatments and Therapies ... Bladder Cancer ... National Cancer Institute ... From the National Institutes of Health ... Learn about the different ways bladder ...
    https://www.cancer.gov/types/bladder/treatment - National Institutes of Health
  10. LactMed: Drugs and Lactation Database From the National Institutes of Health (National Library of Medicine)  
    Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... From the National Institutes of Health ... The LactMed® database contains information ...
    https://www.ncbi.nlm.nih.gov/books/NBK501922 - National Institutes of Health